Based on tumor PD-L1 expression, the median (95% CI) PFS was 4.2 (2.8–7.0) months in the < 1% subgroup and 6.3 (4.8–9.3) months in the ≥ 1% subgroup (Fig. 4B). The gene discussed is CD274; the disease is neoplasm.